About Neutron Therapy
Research Center (NTRC)
Okayama University Neutron Therapy Research Center (NTRC) is BNCT’s new international research and education center.
Policy of Our NTRC
The NTRC consists of the “Drug Research and Development Division” the “Quantum Science and Technology Division” the “International Collaboration Division” and the “Molecular Imaging Division. We would like to create a new field of neutron medicine and precision BNCT by bringing together the best “knowledge” and “skills” in each division. Furthermore, I would like to announce new research discoveries and therapeutic developments that will excite people around the world. At the same time, I will contribute to the development of BNCT for the next generation through BNCT education.
Main Project
- Development of novel boron drugs based on Precision BNCT
- Formation of regional and international exchange hubs centered around BNCT
- Pioneering future-type BNCT through the development of new technologies
- Creation of unique technology through the integration of molecular imaging technologies
- Initiatives aimed at fostering the next generation of BNCT medical professionals and researchers
History of NTRC
| 2015 Feb | Signed Memorandum of Understanding (MOU) between Okayama University, Kagamino-cho and Japan Atomic Energy Agency (JAEA). |
|---|---|
| 2015 Mar | Co-hosted the first international symposium with IAEA at Kagamino-cho. |
| 2016 Mar | Co-hosted the second international symposium with IAEA at Okayama University. |
| 2016 Oct | Signed Practical Arrangements (PA) between IAEA and Okayama University on Cooperation in the Area of Research and Higher Education in Boron Neutron Capture Therapy. |
| 2017 Apr | NTRC inaugurated. |
| 2017 Apr | Division of International Affairs setup under Endowed Chair of Kagamino-cho |
| 2017 Sep | Signed MOU between Nagoya University and Okayama University |
| 2017 Dec | Held the First Symposium of NTRC |
| 2017 Dec | Signed MOU between Okayama University and Osaka Prefecture University |
| 2018 Feb | Okayama University Hospital was assigned as Center for Comprehensive Genomic Medicine by the Ministry of Health, Labor and Welfare (MHLW) |
| 2018 Oct | Started Pharmaceutical Affairs Consultation on R&D Strategy for the new boron drug with the Pharmaceuticals and Medical Devices Agency (PMDA) |
| 2018 Nov | Confirmed onset of a neutron beam by the accelerator-based neutron generator at Nagoya University |
| 2018 Nov | Signed research Agreement with 3-D Matrix Ltd. |
| 2018 Dec | Held the Second Symposium of NTRC |
| 2018 Dec | Started cellular experiments with the neutron generator at Nagoya University. |
| 2019 Dec | Signed Joint Research Agreement for New Boron Agency with Niigata University of Pharmacy and Applied Life Sciences |
| 2019 Apr | Restructure of NTRC |
| 2019 May | Started in vitro experiments of the new boron agency by the neutron generator at Nagoya University. |
| 2019 Jun | Signed the extension of MOU with Nagoya University |
| 2019 Jul | Patented the new drug, OKD-001 |
| 2019 Oct | Promoted investments for OKD-001. |
| 2019 Dec | Held the Third Symposium of NTRC |
| 2020 Jun | Renewed the Practical Arrangements (PA) with IAEA |
| 2021 Jul | Established the postgraduate course ‘Neutron Medicine Course’ |
| 2021 Dec | Held the 5th Symposium of NTRC |
| 2022 Aug | Restructure of NTRC |
| 2022 Dec | Held the 6th Symposium of NTRC |
| 2022 Sep | Held Side event at the 66th IAEA General Conference. |
| 2023 Jun | Signed MOU between Okayama University and Shanghai University |
| 2023 Dec | Held the 7th Symposium of NTRC |